Microalbuminuria
33
1
1
14
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
9.1%
3 terminated out of 33 trials
82.4%
-4.2% vs benchmark
48%
16 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (33)
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
Time Restricted Eating in Patients With Microalbuminuria
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
Dietary Interventions on Glycocalyx Dimensions in South Asian Patients With Diabetic Nephropathy.
REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus
Contrast Nephropathy in Type 2 Diabetes
Screening of Microalbuminuria Using a Semi-quantitative UACR Test
Community-based Microalbuminuria Screening in Patients With Hypertension
Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects
Use of Sitagliptin to Decrease Microalbuminuria
Microalbuminuria as a Cardiovascular Risk Factor (PRECISED Substudy)
Prevention of Renal and Vascular Endstage Disease Intervention Trial
To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes Mellitus
Coronary Artery Plaque Burden and Morphology in Type 2 Diabetes Mellitus.
Microalbuminuria Predicting CIAKI After CAG
Perindopril vs Ramipril for Persistence in MAU Reduction Study
Saxagliptin's Effects on Microalbuminuria Improvement in Type 2 Diabetic Patients
Effects of Low Sodium Intake on the Anti-proteinuric Efficacy in Hypertensive Patient With Olmesartan
Evaluate the Efficacy of Fenofibrate on Microalbuminuria
Resolution of Microalbuminuria and Dysmetabolism Following Bariatric Surgery: Prospective Study